Pharmaceutical composition of an anti-VEGF antibody
US10568951B2 · kind B2 · utility
5Cited by
5References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 13, 2014 |
| Grant date | Feb 25, 2020 |
| Priority date | — |
| Expiry date | Jul 23, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to liquid pharmaceutical formulations for intravitreal injection of an anti-VEGF antibody which does not contain saccharides for use in the treatment of age-related macular degeneration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.